[Cutaneous effects related to the use of tyrosine kinase inhibitors].
Mateus
Christine
C
D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000188:drug therapy; D000279:Administration, Cutaneous; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000505:Alopecia / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D047428:Protein Kinase Inhibitors